25 May 2013
Keywords: teva, granted, approval, galzin, israeli, firm, received
Article | 03 February 1997
- Israeli firm Teva has received US Food and Drug Administrationapproval to market its orphan drug Galzin (zinc acetate) for the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
24 May 2013
© 2013 thepharmaletter.com